MVM Partners has closed its sixth healthcare fund, MVM VI, with $500m in limited partner commitments. Demand was well above the hard cap. MVM has been investing in high growth healthcare businesses since 1997.
MVM VI will continue this broad, global remit with investments in medical technology, pharmaceuticals, biotechnology, diagnostics, life science tools, pharma services and digital health.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
MVM invests in both private and public companies. Typical projected investment in each company is $30 to $60 million, but with capacity for larger investments.
MVM has been investing in high growth healthcare businesses since 1997. MVM VI will continue this broad, global remit with investments in medical technology, pharmaceuticals, biotechnology, diagnostics, life science tools, pharma services and digital health. MVM invests in both private and public companies.
Source: Private Equity Wire
Can’t stop reading? Read more
Fund Friday: Top fundraising news in private equity
Fund Friday: Top fundraising news in private equity Partners Group has closed its latest private...
Ares commits $300m to scale Clearwater’s C-PACE real estate credit platform
Ares commits $300m to scale Clearwater’s C-PACE real estate credit platform Ares has committed up...
GIC-backed Envision AESC explores $2bn Hong Kong IPO
GIC-backed Envision AESC explores $2bn Hong Kong IPO GIC-backed Envision AESC is exploring a Hong...